FiercePharma22d
FDA signs off on Sanofi's insulin biosimilar, the first for Novo Nordisk's rapid-acting NovoLog
The agency has given a thumbs up to Sanofi’s Merilog (insulin-aspart-szjj) as the first biosimilar to Novo Nordisk’s NovoLog for patients ... a multiple-dose 10 mL vial. It is for adults ...
Medical Xpress20d
FDA approves first rapid-acting insulin biosimilar for patients with diabetes
The U.S. Food and Drug Administration has approved Sanofi-Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin ... and a 10-mL multiple-dose vial are included in this ...
California Made a Big Bet on Producing Its Own Insulin, But There’s No ‘Date Certain’ for Delivery
During a hearing, representatives for the Newsom administration said they could not provide a timeline for when ...
The Cardiology Advisor7d
FDA Approves First Rapid-Acting Insulin Biosimilar for Patients With Diabetes
The US Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes mellitus.
Finanznachrichten23d
FDA Approves Merilog Rapid-Acting Insulin Biosimilar For Diabetes
PARIS (dpa-AFX) - The ... dose vial. As a rapid-acting human insulin, Merilog helps to lower mealtime blood sugar spikes to improve control of blood sugar in people with diabetes. Like Novolog ...
Yahoo Finance25d
FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes
Feb. 14, 2025 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin ... multiple-dose vial. Merilog is the third ...
Tyler Morning Telegraph21d
FDA Approves First Rapid-Acting Insulin Biosimilar for Patients With Diabetes
WEDNESDAY, Feb. 19, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog ... mL multiple-dose vial are included ...
Benzinga.com22d
FDA Approves Sanofi's Merilog As First Rapid-Acting Insulin Biosimilar Product For Diabetes
Merilog is available in a 3 mL prefilled pen and a 10 mL vial, joining two long-acting ... In 2023, Sanofi jumped the bandwagon with the other two insulin U.S. giants to lower the price of its ...
Pharmabiz22d
US FDA approves Sanofi-Aventis’ rapid-acting insulin biosimilar product Merilog for improvement of glycaemic control in patients with diabetes
The US Food and Drug Administration (FDA) approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart ... use prefilled pen and a 10 milliliter (mL) multiple-dose vial. Merilog is ...
Business Insider25d
FDA approves Sanofi biosimilar product for treatment of diabetes
The U.S. Food and Drug Administration approved Merilog as biosimilar to Novolog for the improvement ... a 10 milliliter multiple-dose vial. Merilog is the third insulin biosimilar product approved ...